Precigen, Inc. Banner Image

Precigen, Inc.

  • Ticker PGEN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Precigen, Inc. Logo Image
  • 201-500 Employees
  • Based in Germantown, Maryland
Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in their core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Their technologies enable them to find innovative solutions for affordableMore biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.
4.8 / 5.0 (125)

Precigen, Inc. reports have an aggregate usefulness score of 4.8 based on 125 reviews.

Precigen, Inc.

Most Recent Annual Report

Precigen, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Precigen, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!